Evidence map›Paper›PMID 20887814›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2011

Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells.

Kenneth T Thurn, Hans Arora, Tatjana Paunesku, Aiguo Wu, Eric M B Brown, Caroline Doty, Jeff Kremer, Gayle Woloschak

Abstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Assessment of TiOMaterials (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Chronic effects of two rutile TiOParticle and fibre toxicology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Development of FeCancer nanotechnology · 2021
    Article
  18. Review
  19. Prostate Cancer Cellular Uptake of Ternary Titanate Nanotubes/CuFeInternational journal of nanomedicine · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kenneth T ThurnDepartment of Radiation Oncology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Hans Arora
Tatjana Paunesku
Aiguo Wu
Eric M B Brown
Caroline Doty
Jeff Kremer
Gayle Woloschak

Funding

TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancerU54CA119341 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MIRKIN, CHAD A. · 2005 to 2009
$19.9M
SPORE IN BREAST CANCERP50CA089018 · NCI · NORTHWESTERN UNIVERSITY · PI JORDAN, VIRGIL CRAIG · 2000 to 2004
$14.2M
Applications of TiO2-DNA nanocompositesR01EB002100 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLOSCHAK, GAYLE E. · 2005 to 2013
$2.5M
Application of TiO2-DNA nanocomposites to Cancer CellsR01CA107467 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLOSCHAK, GAYLE E. · 2004 to 2006
$960k
NCI NIH HHS CA107467NCI NIH HHS P50 CA089018NCI NIH HHS P50 CA89018NCI NIH HHS R01 CA107467NCI NIH HHS U54 CA119341NIBIB NIH HHS EB002100NIBIB NIH HHS R01 EB002100
6 · The paper itself

Abstract

Nanotechnology has introduced many exciting new tools for the treatment of human diseases. One of the obstacles in its application to that end is the lack of a fundamental understanding of the interaction that occurs between nanoparticles and living cells. This report describes the quantitative analysis of the kinetics and endocytic pathways involved in the uptake of anatase titanium dioxide (TiO(2)) nanoparticles into prostate cancer PC-3M cells. The experiments were performed with TiO(2) nanoconjugates: 6-nm nanoparticles with surface-conjugated fluorescent Alizarin Red S. Results obtained by flow cytometry, fluorescence microscopy, and inductively coupled plasma-mass spectrometry confirmed a complex nanoparticle-cell interaction involving a variety of endocytic mechanisms. The results demonstrated that a temperature, concentration, and time-dependent internalization of the TiO(2) nanoparticles and nanoconjugates occurred via clathrin-mediated endocytosis, caveolin-mediated endocytosis, and macropinocytosis. FROM THE CLINICAL EDITOR: The interaction and uptake of TiO(2) nanoparticles (6-nm) with prostate PC-3M cells was investigated and found to undergo temperature, time, and concentration dependent intracellular transport that was mediated through clathrin pits, caveolae, and macropinocytosis. These results suggest that nanoparticles may widely permeate through tissues and enter almost any active cell through a variety of biological mechanisms, posing both interesting opportunity and possible challenges for systemic use.

Indexed as

Metal NanoparticlesCaveolaeCell Line, TumorClathrinEndocytosisHumansMaleNanotechnologyParticle SizeProstatic NeoplasmsTitaniumClathrinTitaniumtitanium dioxide

Identifiers

PMID20887814
PMCPMC3062699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.